BSE Live
Dec 11, 15:40Prev. Close
345.20
Open Price
343.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 11, 15:45Prev. Close
343.25
Open Price
341.10
Bid Price (Qty.)
347.15 (101)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Gufic Biosciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 356.58 | 350.77 | 297.01 | 255.00 | 213.96 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 3.16 | 14.90 | 11.91 | |
| Revenue From Operations [Net] | 356.58 | 350.77 | 293.86 | 240.10 | 202.05 | |
| Total Operating Revenues | 378.84 | 350.77 | 300.96 | 245.52 | 202.20 | |
| Other Income | 5.79 | 4.17 | 2.94 | 1.44 | 0.66 | |
| Total Revenue | 384.63 | 354.94 | 303.91 | 246.96 | 202.86 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 153.83 | 127.16 | 107.94 | 77.73 | 76.27 | |
| Purchase Of Stock-In Trade | 36.62 | 39.84 | 67.46 | 54.52 | 42.81 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -10.91 | 13.77 | -33.17 | -11.46 | -17.10 | |
| Employee Benefit Expenses | 58.59 | 46.85 | 44.46 | 41.03 | 31.98 | |
| Finance Costs | 13.91 | 10.16 | 8.85 | 6.34 | 5.37 | |
| Depreciation And Amortisation Expenses | 13.86 | 4.65 | 4.30 | 3.68 | 3.79 | |
| Other Expenses | 88.60 | 77.16 | 76.12 | 60.74 | 48.56 | |
| Total Expenses | 354.50 | 319.59 | 275.96 | 232.59 | 191.67 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 30.13 | 35.35 | 27.95 | 14.37 | 11.19 | |
| Exceptional Items | 0.00 | 0.00 | 1.59 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 30.13 | 35.35 | 29.54 | 14.37 | 11.19 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 8.31 | 11.59 | 12.27 | 7.20 | 4.29 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.88 | 1.82 | 1.25 | -1.85 | -0.43 | |
| Tax For Earlier Years | -1.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 7.44 | 13.41 | 13.52 | 5.35 | 3.87 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 22.69 | 21.94 | 16.02 | 9.02 | 7.32 | |
| Profit/Loss From Continuing Operations | 22.69 | 21.94 | 16.02 | 9.02 | 7.32 | |
| Profit/Loss For The Period | 22.69 | 21.94 | 16.02 | 9.02 | 7.32 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 2.34 | 2.82 | 2.07 | 1.17 | 0.95 | |
| Diluted EPS (Rs.) | 2.34 | 2.82 | 2.07 | 1.17 | 0.95 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 34.27 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 42.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | |
| Tax On Dividend | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
| Equity Dividend Rate (%) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y